BioPharma Credit PLC (OTCMKTS:BOPCF) Short Interest Up 85.7% in December

BioPharma Credit PLC (OTCMKTS:BOPCF) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 13 shares, an increase of 85.7% from the December 15th total of 7 shares. Based on an average daily volume of 18,183 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 18,183 shares, the days-to-cover ratio is currently 0.0 days.

BioPharma Credit Price Performance

BioPharma Credit stock opened at $0.85 on Thursday. The company has a fifty day simple moving average of $0.89 and a 200-day simple moving average of $0.89. BioPharma Credit has a 52-week low of $0.78 and a 52-week high of $0.95.

BioPharma Credit Company Profile

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.